← SynDRA
AROTINOLOL
SynDRA canonical compound SYN0003676 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRB1 | ADRB2 | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | hypertension | tremors |
|---|
| Disease area | cardiology | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- adrenergic receptor antagonist
Drug classes
- Adrenergic Agents
- Adrenergic alpha-Antagonists
- Adrenergic Antagonists
- Adrenergic beta-Antagonists
- Neurotransmitter Agents
Cross-references
Synonyms
- arotinolol hydrochloride
- arotinolol HCl
- NSC-317940
- Arotinololum
- NSC 317940
- S 596
- RefChem:114161
- DTXCID302619
- Arotinolol [INN]
- Arotinololum [Latin]
- C15H21N3O2S3
- (+-)-Arotinolol
- UNII-394E3P3B99
- MFCD00865895
- Arotinolol (INN)
- Arotinolol free base
- AROTINOLOL [MI]
- AROTINOLOL [WHO-DD]
- SCHEMBL80713
- BDBM81885
- CHEBI:135569
- MSK10613
- NSC317940
- AKOS016014208
- HY-122537A
- BS-42433
- CAS_52560-77-7
- DB-055146
- CS-0102757
- C76165
- D07465
- SBI-0654652.0001
- F324647
- L013390
- SR-01000944984
- SR-01000944984-1
- BRD-A28044053-001-01-7
- آروتینولول
Look up AROTINOLOL in the interactive SynDRA portal →